Sterling Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Sterling Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.7K	Sell	245 -194	-44%	-$3.39K	﹤0.01%	2774
2026 Q1	$8.42K	Sell	439 -5	-1%	-$109	﹤0.01%	2470
2025 Q4	$9.76K	Buy	444 +282	+174%	+$5.09K	﹤0.01%	2611
2025 Q3	$1.97K	Buy	162 +1	+0.6%	+$14	﹤0.01%	2981
2025 Q2	$3K	Buy	161 +94	+140%	+$1.86K	﹤0.01%	2785
2025 Q1	$1.28K	Hold	67	–	–	﹤0.01%	2730
2024 Q4	$2.41K	Hold	67	–	–	﹤0.01%	2733
2024 Q3	$2.84K	Buy	+67	New	+$2.84K	﹤0.01%	2019

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Sterling Capital Management's TNDM Position: Q2 2026 in Review

Sterling Capital Management reduced its Tandem Diabetes Care (TNDM) stake by 44% in Q2 2026, selling an estimated $3.39K and leaving 245 shares worth $3.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2774.

Sterling Capital Management first reported a position in TNDM in Q3 2024 and has held it in 8 quarters since. The position peaked at $9.76K in Q4 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

Sterling Capital Management held 245 shares of Tandem Diabetes Care worth $3.7K as of Q2 2026.
Sterling Capital Management sold 194 Tandem Diabetes Care shares in Q2 2026, an estimated $3.39K.
Tandem Diabetes Care made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2774 holding.
Sterling Capital Management first reported a position in Tandem Diabetes Care in Q3 2024 and has held it in 8 quarters since.
Sterling Capital Management's Tandem Diabetes Care position peaked at $9.76K in Q4 2025.
274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.